|
Celal |
Albayrak |
Germany |
Production of Drug Loaded Nano- and Microparticles using ImSus® Technology |
|
Karine |
Andrieux |
France |
Nanoparticles for theragnostic of Alzheimer disease |
|
Simon |
Benita |
Israel |
A novel nanotechnology platform for improving the oral bioavailability of P-gp and CYP3A4 substrate drugs |
|
Hasan Basri |
Çakmak |
Turkey |
Biodegradable drug delivery systems in ophtalmology |
|
Sema |
Çalış |
Turkey |
Overview of drug/device combinations and use in local therapies |
|
Yılmaz |
Çapan |
Turkey |
|
|
Carla |
Caramella |
Italy |
A therapeutic platform for wound healing: from gels to nanoparticles |
|
Martyn C. |
Davis |
United Kingdom |
|
|
Emir Baki |
Denkbaş |
Turkey |
|
|
Banu |
Eyüboğlu |
Alvimedica, Turkey |
Drug-Device Combination and Local Drug Delivery |
|
Ferhad |
Farshi |
Abdi İbrahim, Turkey |
Fixed dose combinations – overcoming the technological challenges |
|
Hamid |
Ghandehari |
United States |
Gold nanorod-mediated hyperthermia: A tool to enhance targeted delivery of macromolecular therapeutics |
|
Achim |
Göpferich |
Germany |
|
|
R. Neslihan |
Gürsoy |
Turkey |
|
|
Seungpyo |
Hong |
United States |
Biomimetic Nanotechnology to Tackle Cancer: Targeted drug delivery and tumor cell capturing |
|
Hans |
Junginger |
Netherlands |
Chitosan and TMC microparticles for oral vaccination against Japanese Encephalitis Virus (JEV) |
|
Emin |
Kansu |
Turkey |
Current Perspectives on Anti-Cancer Monoclonal Antibodies |
|
Serpil |
Kışlalıoğlu |
United States |
A critical evaluation of the methods used to reduce the particle size of drug substances |
|
Uday |
Kompella |
United States |
Protein drug delivery to the back of the eye |
|
Alf |
Lamprecht |
Germany |
Bioadhesive carriers at disrupted absorption barriers |
|
Cem |
Mocan |
Turkey |
The Eye: A Target Organ For Pharmaceutical Applications |
|
Marcelo |
Nacucchio |
Argentina |
Medical Devices and DDS applications: Risk analysis |
|
Hayat |
Önyüksel |
United States |
|
|
Tamas |
Paal |
Hungary |
Supergenerics - definition and practical issues in the EU / Fixed combinations - regulatory issues and traps to be avoided in the EU |
|
Sibel |
Pehlivan |
Turkey |
|
|
Woei |
Ping Cheng |
United Kingdom |
The design of smart, functionalised self-assembled delivery system for biomedical application |
|
Michael J. |
Rathbone |
Australia |
Veterinary Applications of Medical Devices |
|
Carlo |
Rossi |
Italy |
Advances in fighting tuberculosis: second line drug reappraisal through new formulations |
|
Paola |
Russo |
Italy |
Design and development of dry powder inhalers for cystic fibrosis patients |
|
Tom |
Sam |
Netherlands |
Designing Medical Devices for drug delivery / European regulatory requirements for Medical Devices / Drug-Device Combination Products: Development and Regulatory Challenges |
|
Rana Nomak |
Sanyal |
Turkey |
|
|
Christian |
Schöneich |
United States |
Formation and consequences of protein hydroperoxides for the formulation of biotechnology products |
|
Sevda |
Şenel |
Turkey |
Vaccines |
|
Vinod |
Shah |
United States |
Supergenerics |
|
Nurşen |
Ünlü |
Turkey |
|
|
Ercan |
Varlıbaş |
Turkey |
|
|
Clive |
Wilson |
United Kingdom |
Biological variability and depot release technologies / Ocular drug delivery to the vitreous |
